Bio Green Med Solution, Inc. (BGMSP) Cash from Investing Activities (2010 - 2026)

Bio Green Med Solution (BGMSP) has reported Cash from Investing Activities for 14 consecutive years, with -$1000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at -$1000.0 (changed N/A YoY), while the FY2023 annual figure was -$6000.0, up 14.29% from the prior year.
• Cash from Investing Activities rose to -$1000.0 in Q1 2026 per BGMSP's latest filing, from -$6000.0 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$1000.0 in Q1 2026 and bottomed at -$6000.0 in Q1 2023.
• Historically, Cash from Investing Activities has averaged -$3500.0 across 3 years, with a median of -$3500.0 in 2022.
• On a YoY basis, Cash from Investing Activities climbed as much as 94.87% in 2022 and fell as far as 104.84% in 2022.
• Bio Green Med Solution's Cash from Investing Activities stood at -$3000.0 in 2022, then sank by 100.0% to -$6000.0 in 2023, then surged by 83.33% to -$1000.0 in 2026.
• Business Quant data shows BGMSP's Cash from Investing Activities at -$1000.0 in Q1 2026, -$6000.0 in Q1 2023, and -$3000.0 in Q2 2022.